X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
humans (38) 38
ophthalmology (32) 32
female (23) 23
male (22) 22
aged (21) 21
eye diseases (20) 20
macular degeneration (19) 19
age-related macular degeneration (17) 17
macular degeneration - genetics (17) 17
article (13) 13
risk factors (12) 12
complement factor-h (10) 10
follow-up studies (10) 10
sense organs (10) 10
tomography, optical coherence (10) 10
middle aged (9) 9
polymorphism, single nucleotide (9) 9
surgery (9) 9
aged, 80 and over (8) 8
genetic predisposition to disease (8) 8
intravitreal injections (8) 8
retina (8) 8
fluorescein angiography (7) 7
genetic structures (7) 7
genome-wide association study (7) 7
genotype (7) 7
susceptibility (7) 7
case-control studies (6) 6
genetics & heredity (6) 6
proteins - genetics (6) 6
retrospective studies (6) 6
risk (6) 6
tomography (6) 6
vascular endothelial growth factor (6) 6
abridged index medicus (5) 5
adult (5) 5
bevacizumab (5) 5
disease (5) 5
genetic aspects (5) 5
genetics (5) 5
genome-wide association (5) 5
medical imaging (5) 5
vascular endothelial growth factor a - antagonists & inhibitors (5) 5
visual acuity - physiology (5) 5
age-related maculopathy (4) 4
age-related maculopathy susceptibility 2 (4) 4
angiogenesis inhibitors - therapeutic use (4) 4
arms2 (4) 4
clinical trials (4) 4
complement factor h (4) 4
diabetic retinopathy (4) 4
drug therapy (4) 4
fundus oculi (4) 4
gene (4) 4
gene-environment interaction (4) 4
genes (4) 4
identification and classification (4) 4
macular degeneration - drug therapy (4) 4
maculopathy (4) 4
pharmacogenetics (4) 4
physiological aspects (4) 4
polymorphism (4) 4
ranibizumab (4) 4
research (4) 4
retinal diseases - drug therapy (4) 4
risk-factors (4) 4
smoking (4) 4
studies (4) 4
time factors (4) 4
visual acuity (4) 4
age (3) 3
alleles (3) 3
analysis (3) 3
angiography (3) 3
antibodies, monoclonal, humanized (3) 3
article subject (3) 3
association (3) 3
atrophy (3) 3
care and treatment (3) 3
case report (3) 3
choroidal neovascularization (3) 3
choroidal neovascularization - drug therapy (3) 3
chromosome 10q26 (3) 3
cigarette-smoking (3) 3
complement factor h - genetics (3) 3
dietary supplements (3) 3
endophthalmitis - microbiology (3) 3
eye infections, bacterial - microbiology (3) 3
factor-b (3) 3
genetic variation (3) 3
genomes (3) 3
geographic atrophy (3) 3
glucocorticoids - administration & dosage (3) 3
health aspects (3) 3
htra1 (3) 3
macular degeneration - metabolism (3) 3
metaanalysis (3) 3
mutation (3) 3
optical coherence tomography (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular and Cellular Pharmacology, ISSN 1938-1247, 2009, Volume 1, Issue 4, pp. 222 - 227
Diabetic retinopathy is the leading cause of vision loss among working-age people in the United States. The hallmark of diabetic retinopathy is vascular... 
Corticosteroid | Diabetic retinopathy | Macular edema | Diabetes | Proliferative diabetic retinopathy | Vascular endothelial growth factor
Journal Article
Journal of pediatric ophthalmology and strabismus, 08/2009
Best's disease is an autosomal dominant disorder characterized by bilateral vitelliform macular lesions that progress through several stages throughout life.... 
Journal Article
Human Genetics, ISSN 0340-6717, 5/2010, Volume 127, Issue 5, pp. 595 - 602
Controversy remains as to which gene at the chromosome 10q26 locus confers risk for age-related macular degeneration (AMD) and statistical genetic analysis is... 
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases
Journal Article
Retinal Cases and Brief Reports, ISSN 1935-1089, 03/2010, Volume 4, Issue 2, pp. 187 - 189
To describe hypertensive optic neuropathy and choroidopathy caused by renal failure in an 18-year-old woman. The clinical and angiographic findings of a young... 
Hypertensive optic neuropathy | Hypertensive emergency | Hypertensive retinopathy | Hypertensive choroidopathy | Optic nerve swelling | Malignant hypertension | Exudative retinal detachment
Journal Article
by Wei Chen and Dwight Stambolian and Albert O. Edwards and Kari E. Branham and Mohammad Othman and Johanna Jakobsdottir and Nirubol Tosakulwong and Margaret A. Pericak-Vance and Peter A. Campochiaro and Michael L. Klein and Perciliz L. Tan and Yvette P. Conley and Atsuhiro Kanda and Laura Kopplin and Yanming Li and Katherine J. Augustaitis and Athanasios J. Karoukis and William K. Scott and Anita Agarwal and Jaclyn L. Kovach and Stephen G. Schwartz and Eric A. Postel and Matthew Brooks and Keith H. Baratz and William L. Brown and Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group and Alexander J. Brucker and Anton Orlin and Gary Brown and Allen Ho and Carl Regillo and Larry Donoso and Lifeng Tian and Brian Kaderli and Dexter Hadley and Stephanie A. Hagstrom and Neal S. Peachey and Ronald Klein and Barbara E. K. Klein and Norimoto Gotoh and Kenji Yamashiro and Frederick Ferris and Jesen A. Fagerness and Robyn Reynolds and Lindsay A. Farrer and Ivana K. Kim and Joan W. Miller and Marta Cortón and Angel Carracedo and Manuel Sanchez-Salorio and Elizabeth W. Pugh and Kimberly F. Doheny and Maria Brion and Margaret M. DeAngelis and Daniel E. Weeks and Donald J. Zack and Emily Y. Chew and John R. Heckenlively and Nagahisa Yoshimura and Sudha K. Iyengar and Peter J. Francis and Nicholas Katsanis and Johanna M. Seddon and Jonathan L. Haines and Michael B. Gorin and Gonçalo R. Abecasis and Anand Swaroop and Mark T. Keating and Complications Age-Related Macular and Complications of Age-Related Macular Degeneration Prevention Trial Research Group and Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2010, Volume 107, Issue 16, pp. 7401 - 7406
Journal Article
Journal Article
Retina, ISSN 0275-004X, 04/2011, Volume 31, Issue 4, pp. 662 - 668
Purpose: To assess the rate of infectious endophthalmitis and to describe the clinical and microbiological features of eyes that develop clinically suspected... 
VERTEPORFIN | INJECTION | SAFETY | bevacizumab | OPHTHALMOLOGY | MACULAR DEGENERATION | endophthalmitis | intravitreal injection | anti-vascular endothelial growth factor | pegaptanib | age-related macular degeneration | ranibizumab
Journal Article
Journal Article
Retina Today, 10/2011, Issue OCTOBER, pp. 78 - 79
Journal Article
Journal of Ophthalmology, ISSN 2090-004X, 2012, Volume 2012, pp. 786870 - 7
Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration... 
MEDICINE, RESEARCH & EXPERIMENTAL | COMPLEMENT FACTOR-H | INTRAVITREAL BEVACIZUMAB AVASTIN | THERAPY | VERTEPORFIN | PHARMACOKINETICS | OPHTHALMOLOGY | EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION | MACULAR DEGENERATION | REGIMEN | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Review
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.